Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.

Sharma B, Singh N.

Psychopharmacology (Berl). 2012 Oct;223(3):307-17. doi: 10.1007/s00213-012-2718-9. Epub 2012 Apr 20.

PMID:
22526544
2.

Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia.

Sharma B, Singh N.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):207-15. doi: 10.1016/j.pnpbp.2012.03.013. Epub 2012 Apr 4.

PMID:
22510463
3.

Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor.

Sharma B, Singh N.

Pharmacol Biochem Behav. 2012 Jul;102(1):101-8. doi: 10.1016/j.pbb.2012.03.029. Epub 2012 Apr 6.

PMID:
22507914
4.

Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease.

Gupta S, Sharma B.

Brain Res Bull. 2014 Mar;102:57-68. doi: 10.1016/j.brainresbull.2014.02.007. Epub 2014 Feb 28.

PMID:
24582883
6.

Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.

Sharma B, Sharma PM.

Toxicol Appl Pharmacol. 2013 Nov 15;273(1):180-8. doi: 10.1016/j.taap.2013.07.017. Epub 2013 Aug 3.

PMID:
23921152
8.

Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats.

Nakano D, Itoh C, Ishii F, Kawanishi H, Takaoka M, Kiso Y, Tsuruoka N, Tanaka T, Matsumura Y.

Biol Pharm Bull. 2003 Dec;26(12):1701-5.

9.

Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.

Gómez-Guzmán M, Jiménez R, Sánchez M, Zarzuelo MJ, Galindo P, Quintela AM, López-Sepúlveda R, Romero M, Tamargo J, Vargas F, Pérez-Vizcaíno F, Duarte J.

Free Radic Biol Med. 2012 Jan 1;52(1):70-9. doi: 10.1016/j.freeradbiomed.2011.09.015. Epub 2011 Sep 22.

PMID:
22001745
10.

Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension.

Millette E, Demeilliers B, Wu R, Laplante MA, El Midaoui A, Moreau P, Lamontagne D, de Champlain J.

J Hypertens. 2003 Jan;21(1):125-35.

PMID:
12544444
11.

Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.

Nunes VW, Fortes ZB, Nigro D, Carvalho MH, Zorn TM, Scivoletto R.

Gen Pharmacol. 2000 Feb;34(2):117-25.

PMID:
10974419
13.

Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats.

Sharma B, Singh N.

Pharmacol Biochem Behav. 2011 Dec;100(2):320-9. doi: 10.1016/j.pbb.2011.08.020. Epub 2011 Aug 27.

PMID:
21893084
14.

Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.

Bhatia J, Tabassum F, Sharma AK, Bharti S, Golechha M, Joshi S, Sayeed Akhatar M, Srivastava AK, Arya DS.

Cardiovasc Toxicol. 2011 Sep;11(3):272-9. doi: 10.1007/s12012-011-9122-2.

PMID:
21748534
15.

Arterial function in mineralocorticoid-NaCl hypertension: influence of angiotensin-converting enzyme inhibition.

Mäkynen H, Kähönen M, Wu X, Hutri-Kähönen N, Tolvanen JP, Pörsti I.

Pharmacol Toxicol. 1997 Oct;81(4):180-9.

PMID:
9353849
16.
17.
18.

Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.

Zhou MS, Schulman IH, Raij L.

J Hypertens. 2010 Mar;28(3):527-35. doi: 10.1097/HJH.0b013e3283340da8.

PMID:
19898250
20.

Lowering of blood pressure improves endothelial dysfunction by increase of nitric oxide production in hypertensive rats.

Hatta T, Nakata T, Harada S, Kiyama M, Moriguchi J, Morimoto S, Itoh H, Sasaki S, Takeda K, Nakagawa M.

Hypertens Res. 2002 May;25(3):455-60.

Supplemental Content

Support Center